|
Ann Tsukamoto, Ph.D., was appointed Chief Operating Officer in November 2006. Prior to that, she served as Vice President, Research and Development. Dr. Tsukamoto has ~20 years experience in stem cell biology and was a co-discoverer of the human hematopoietic stem cell while at SyStemix, Inc., and she played a leading role in the launch of the clinical research program for the hematopoietic stem cell. Under her direction at StemCells Inc., the scientific team has discovered the human central nervous system stem cell, a population of human liver engrafting cells and a candidate pancreas stem cell. Dr. Tsukamoto received her Ph.D. from the University of California, Los Angeles and did postdoctoral research with Dr. Harold Varmus at the University of California, San Francisco where she worked on the wnt-1 gene, which is a key player in the stem cell self-renewal pathway. Dr. Tsukamoto is an inventor on six issued U.S. patents related to the human hematopoietic stem cell. | 